Aspiriant LLC’s Intercontinental Exchange ICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,650
Closed -$267K 344
2025
Q4
$267K Buy
1,650
+240
+17% +$37.6K 0.01% 288
2025
Q3
$238K Sell
1,410
-210
-13% -$37.5K 0.01% 280
2025
Q2
$297K Buy
1,620
+130
+9% +$22.3K 0.01% 254
2025
Q1
$257K Buy
1,490
+19
+1% +$3.11K 0.01% 256
2024
Q4
$219K Buy
1,471
+49
+3% +$7.76K 0.01% 272
2024
Q3
$228K Buy
+1,422
New +$219K 0.01% 265
2024
Q2
Sell
-1,536
Closed -$211K 308
2024
Q1
$211K Sell
1,536
-128
-8% -$17K 0.01% 305
2023
Q4
$214K Sell
1,664
-330
-17% -$37.4K 0.01% 288
2023
Q3
$219K Buy
+1,994
New +$228K 0.01% 264

Other funds holding ICE

Aspiriant LLC's ICE Position: Q1 2026 in Review

Aspiriant LLC sold out of Intercontinental Exchange (ICE) in Q1 2026, closing a stake of 1,650 shares — an estimated $267K sold.

Aspiriant LLC first reported a position in ICE in Q3 2023 and held it in 9 quarters. The position peaked at $297K in Q2 2025. 1,719 funds tracked by Wall St. Rank hold ICE as of Q1 2026.

  • Aspiriant LLC reported no remaining Intercontinental Exchange position as of Q1 2026 after selling out during the quarter.
  • Aspiriant LLC sold 1,650 Intercontinental Exchange shares in Q1 2026, an estimated $267K.
  • Aspiriant LLC first reported a position in Intercontinental Exchange in Q3 2023 and held it in 9 quarters.
  • Aspiriant LLC's Intercontinental Exchange position peaked at $297K in Q2 2025.
  • 1,719 funds tracked by Wall St. Rank held Intercontinental Exchange as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.